Skip to content
Governance Register
Sign inFind yourself
Find yourselfSign in
Search How it works For organisations For professionals

Edition

United Kingdom (current)IrelandUnited StatesNew ZealandCanadaAustraliaScotlandNorthern Ireland

Company · London

Glaxo Operations UK Limited

Manufacture of pharmaceutical preparations

How am I connected?
More
View network map Report an issue

Official record Companies House · updated 27th September 2026 · Sources

Network

The large node is Glaxo Operations UK Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.

Who leads it

Previous officers 43

  1. Richard John Latchford 2021-2022 Director View profile
  2. Erika Patteson-Brent 2020-2021 Director View profile
  3. Joseph James Power 2019-2020 Director View profile
  4. Sheila Mullins 2019-2020 Director View profile
  5. Freek Jongen 2017-2020 Director View profile
  6. Alan George Burns 2017-2019 Director View profile
  7. Regis Jean-Pierre Simard 2016-2019 Director View profile
  8. Riccardo Calliano 2014-2017 Director View profile
  9. Ian Mccubbin 2013-2017 Director View profile
  10. Matthew Creighton Adcock 2013-2014 Director View profile
  11. Stuart Hepburn 2012-2016 Director View profile
  12. Neil O'Hara 2010-2013 Director View profile
  13. Ian Cardwell 2010-2011 Director View profile
  14. John Bell Elliot 2003-2006 Director View profile
  15. Stephen Jordan 2003-2010 Director View profile
  16. David John Jones 2003-2009 Director View profile
  17. Jean Paul Reynaud 2003-2013 Director View profile
  18. Glaxo Group Limited 2002-2003 Corporate-director View profile
  19. Dr Alan Menzies Bell 1999-2001 Director View profile
  20. Timothy John Miller 1999-2000 Director View profile
  21. Timothy Cyril Tyson 1998-2002 Director View profile
  22. Paul Lawrence Bruce 1997-1998 Director View profile
  23. Philip Henry Keller 1997-1997 Director View profile
  24. Jeffrey Royston Baxter 1997-2001 Director View profile
  25. Pulman, David, Doctor 1997-2003 Director View profile
  26. Dr Joseph Caldwell 1997-1998 Director View profile
  27. Dr Barry John Price 1995-1995 Director View profile
  28. Christopher Charles Bolingbroke Waights 1994-1995 Director View profile
  29. Ashley Readshaw 1993-1997 Director View profile
  30. Simon Christopher Cartmell 1993-1995 Director View profile
  31. Dr Ian Alexander Thomson Mcinnes 1993-1996 Director View profile
  32. Franz Bernhard Humer 1993 Director View profile
  33. James Kennedy 1993 Director View profile
  34. Dr Christopher Baker 1993 Director View profile
  35. Philip Edward Parkes 1993 Director View profile
  36. Stanley Clive Challoner 1994 Director View profile
  37. Dr Graham Joseph Blaker 1998 Director View profile
  38. John Stanley Higham 1993 Director View profile
  39. Graham John Vitty 1994 Director View profile
  40. Dr John Malcolm Padfield 1994 Director View profile
  41. Richard James Stephens 2003-2007 Secretary View profile
  42. Simon Michael Bicknell 1994-1998 Secretary View profile
  43. Christopher Lindsay Christian 1994 Secretary View profile

Directors and secretaries as filed at Companies House.

Do you help lead this organisation? Set up its network · How it works

About

What it does
Manufacture of pharmaceutical preparations
Incorporated
01/01/1962
Registered office
London

Ownership

Owned by (1) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.

Group

  1. Glaxo Operations UK Limited is controlled by Glaxo Group Limited
    Evidence
    active 75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06 · source: Companies House PSC register
  2. Glaxo Group Limited is controlled by Glaxosmithkline Finance PLC
    Evidence
    active 75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06 · source: Companies House PSC register
  3. Glaxosmithkline Finance PLC is controlled by Glaxosmithkline Holdings Limited
    Evidence
    active 75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06 · source: Companies House PSC register
  4. Glaxosmithkline Holdings Limited is controlled by GSK PLC
    Evidence
    active 75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06 · source: Companies House PSC register

Ultimately controlled by GSK PLC.

86 other companies in this group

Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.

Board analysis

Board DNA

How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.

2 directors on the board

5.1y median 5.1y
average tenure
5.9y
longest tenure

Directors past 6 years

First-time vs portfolio directors

First-time (1)

Portfolio (1)

0
also govern a charity
0
left in the last 12 months
1
corporate seats

Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.

Manufacturing 1

The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.

Sources

Official record from Companies House. Governance Register calculates the connections.

Record details
Company number
00711851
Status
Active
Type
Private Limited Company
Accounts next due
30/09/2027
Edition
Register edition compiled 27th September 2026
Labels
Official record from Companies House · Calculated derived by Governance Register.

Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data